BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29663445)

  • 21. Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen.
    Wang YM; Ng WC; Lo SK
    J Gastroenterol; 1999 Oct; 34(5):600-6. PubMed ID: 10535488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs.
    Lee BS; Cho YK; Jeong SH; Lee JH; Lee D; Park NH; Ki M;
    J Med Virol; 2013 Aug; 85(8):1327-33. PubMed ID: 23723057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus.
    Sayiner AA; Ozcan A; Sengonul A
    J Med Virol; 2008 Mar; 80(3):405-10. PubMed ID: 18205223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re-evaluation of HBsAg seroclearance.
    Seto WK; Tanaka Y; Wong DK; Shinkai N; Cheung KS; Liu KS; Fung J; Lai CL; Yuen MF
    Liver Int; 2016 May; 36(5):642-50. PubMed ID: 26474013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers.
    Kitab B; El Feydi AE; Afifi R; Derdabi O; Cherradi Y; Benazzouz M; Rebbani K; Brahim I; Salih Alj H; Zoulim F; Trepo C; Chemin I; Ezzikouri S; Benjelloun S
    J Infect; 2011 Jul; 63(1):66-75. PubMed ID: 21640384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification.
    Pancher M; Désiré N; Ngo Y; Akhavan S; Pallier C; Poynard T; Thibault V
    J Clin Virol; 2015 Jan; 62():32-7. PubMed ID: 25542467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.
    Weinberger KM; Bauer T; Böhm S; Jilg W
    J Gen Virol; 2000 May; 81(Pt 5):1165-74. PubMed ID: 10769057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.
    Lu HY; Zeng Z; Xu XY; Zhang NL; Yu M; Gong WB
    World J Gastroenterol; 2006 Jul; 12(26):4219-23. PubMed ID: 16830379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
    Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
    Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia.
    Lazarevic I; Cupic M; Delic D; Svirtlih NS; Simonovic J; Jovanovic T
    J Med Virol; 2010 Jul; 82(7):1160-7. PubMed ID: 20513079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load.
    Jin ZZ; Jin FF; Liu X; Liu N; Wen F; Lou JL
    Braz J Infect Dis; 2019; 23(5):343-351. PubMed ID: 31542378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [S gene mutations in HBsAg/HBsAb double positive chronic hepatitis B patients].
    Zhang ZH; Peng J; Xia JB; Tian YJ; Jiang M; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):266-70. PubMed ID: 19403024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
    J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
    Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
    J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and serological characterization of hepatitis B virus genotype A and D infected blood donors in Poland.
    Grabarczyk P; Garmiri P; Liszewski G; Doucet D; Sulkowska E; Brojer E; Allain JP;
    J Viral Hepat; 2010 Jun; 17(6):444-52. PubMed ID: 19780948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.
    Salpini R; Colagrossi L; Bellocchi MC; Surdo M; Becker C; Alteri C; Aragri M; Ricciardi A; Armenia D; Pollicita M; Di Santo F; Carioti L; Louzoun Y; Mastroianni CM; Lichtner M; Paoloni M; Esposito M; D'Amore C; Marrone A; Marignani M; Sarrecchia C; Sarmati L; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V
    Hepatology; 2015 Mar; 61(3):823-33. PubMed ID: 25418031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients.
    Yamani LN; Yano Y; Utsumi T; Juniastuti ; Wandono H; Widjanarko D; Triantanoe A; Wasityastuti W; Liang Y; Okada R; Tanahashi T; Murakami Y; Azuma T; Soetjipto ; Lusida MI; Hayashi Y
    J Clin Microbiol; 2015 Oct; 53(10):3165-75. PubMed ID: 26202119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies.
    Cuestas ML; Mathet VL; Ruiz V; Minassian ML; Rivero C; Sala A; Corach D; Alessio A; Pozzati M; Frider B; Oubiña JR
    J Clin Microbiol; 2006 Jun; 44(6):2191-8. PubMed ID: 16757620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir.
    de Niet A; Jansen L; Zaaijer HL; Klause U; Takkenberg B; Janssen HL; Chu T; Petric R; Reesink HW
    Antivir Ther; 2014; 19(3):259-67. PubMed ID: 24256626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays.
    Veropalumbo E; Marrone A; Vallefuoco L; Perruolo G; Orlando R; Scordino F; Tosone G; Zampino R; Trani B; Genovese A; Spadaro G; D'Orio C; Portella G
    Intervirology; 2010; 53(3):183-7. PubMed ID: 20197685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.